Close

Leading CPO makes multi-million-pound investment in new packaging equipment

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has announced a multi-million-pound investment in new packaging equipment across its sites in the UK and Ireland.

The company, which specialises in end-to-end supply chain services, made the decision to invest in line with increasing demand for its manufacturing & packaging capabilities from its growing pharma and biotech client portfolio.

The investment includes equipment for the company’s blister and bottle lines, vial labelling, stability chambers and cold storage capacity.

Vincent Dunne, CEO at Wasdell, said: “We are committed to continual investment into our capabilities. In addition to meeting increased demand, our new packaging equipment will allow us to maintain the swift turnaround times and flexible service we are well known for in the industry.

“This investment is at an exciting stage in the growth of the group, and part of a long-term investment plan to expand our capacity & capabilities.”

The equipment will be installed across all Wasdell’s sites in the UK and Ireland, including the recently opened Dundalk facility.

Martin Tedham, Wasdell Group Chairman added “The investment will also support our expanding customer base , particularly US life sciences companies, as they continue to source a provider that can readily navigate the European market and specialises in small-mid batch sizes.”

The Wasdell Group offers services across manufacturing, packaging and storage and distribution.

Latest stories

Related stories

How Language Barriers Impact Non-Native English Speakers in Healthcare

Language barriers create significant challenges for non-native English speakers...

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

Pharma Support Powers Sofinnova Biotech Acceleration Fund

Sofinnova Partners Closes €165M Biotech Acceleration Fund with Strong...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back